Analytical testing, QC

FDA embraces outsourcing

FDA embraces outsourcing

By Kirsty Barnes

The US Food and Drug Administration (FDA) is following the growing
pharma industry trend by embracing outsourcing as part of a
cost-saving drive - a move that is attracting strong opposition.

Follow us

Product Innovations

Liver Disease Capabilities

Liver Disease Capabilities

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...